← Leaderboards
John Koleng
Via Therapeutics, Llc
$3,599,145
Attributed
$3,599,145
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3M · FY2018–20$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
Funding mix
By agency
NIH$3,599,145 · 1
By mechanism
N44$2,999,221 · 1
N01$599,924 · 1
Top collaborators
No co-investigators on record.
Most similar at Via Therapeutics, Llc
Same institution · by research overlap
- Zachary N Warnken$1,027,895
- Zachary Warnken$1,468,122
Others in their field
Other Emerging Leaders on “Tuberculosis Treatment”
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$72,037,072
- Michael Dignam · National Institute Of Allergy And Infectious Diseases$31,845,607
- Thomas Dick · Rbhs-New Jersey Medical School$15,241,285
- Virginia Kan · George Washington University$13,363,264
- Magdalena Elzbieta Sobieszczyk · Columbia University Health Sciences$12,286,513
- Nadine Georges Rouphael · Emory University$10,262,035
Research focus
Tuberculosis TreatmentAlveolar MacrophagesAnimalsTuberculosis DrugsAdverse EventBangladeshBypassCaviaCostCost EfficientDrug ResistanceEffectivenessFormulationHandInhalationInhalatorsLeprosyLungMulti-Drug ResistanceOralPharmaceutical PreparationsPowder Dose FormRegimenReproducibility